03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Accolate* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | AstraZeneca |
Responsible Party | AstraZeneca UK Ltd |
Origin | UK |
Manufacturer | AstraZeneca UK Ltd |
Origin | UK |
ATC | R03DC01 |
Accolate* :
Accolate* :
Accolate* :
Accolate* :
Accolate* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Agranulocytosis | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
Blisters (Vesicle) | Rare |
Cephalea | Common |
Contusion | Rare |
Diarrhoea (Diarrhea) | Common |
Dizziness | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
Hepatitis | Rare |
Hepatitis fulminant | Very rare |
Hyperbilirubinaemia | Uncommon |
Hypersensitivity | Uncommon |
Hypoesthesia | Uncommon |
Infection | Very Common |
Insomnia | Uncommon |
Malaise | Uncommon |
Myalgia | Common |
Nausea | Common |
Nightmares | Uncommon |
Oedema | Uncommon |
Paraesthesia (paresthesia) | Uncommon |
Pruritus | Uncommon |
Skin Eruption | Common |
Transaminases increased | Common |
Urticaria | Uncommon |
Vomiting | Common |
Accolate* :
NB : Products With Same Indication |
Different Units By MoH Code
Accolate* MoH 1339 :
Form | Tablet |
Package Size | Box of 56 |
Strength | 20mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 236877/99 |
Submission date | 01/01/1999 |
Registration Year | 1999 |
Archived Date | 2018 |
Price Comparison
● Country: | KSA | |
● Package Size: | 56 | |
● Public Price: | 142.5 SAR | ( 3,368,700.00 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 2,5446 SAR | ( 47,280.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | UK | |
● Package Size: | 56 | |
● Public Price: | 17.75 GBP | ( 2,017,269.75 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 0,317 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Switzerland | |
● Package Size: | 60 | |
● Public Price: | 50.55 CHF | ( 5,227,881.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 0,8425 CHF | ( 0.00 LBP ) |
● Exfactory Price: | 29.75 CHF | |
● Pricing Date: | 25/01/2019 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 60 | |
● Public Price: | 45.97 EUR | ( 4,453,389.72 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 0,7662 EUR | ( 0.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Finland | |
● Package Size: | 98 | |
● Public Price: | 47.27 EUR | ( 4,579,328.52 LBP ) |
● Pack size unit used: | 98 | |
● Cost/Unit: | 0,4823 EUR | ( 0.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 24/10/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Italy | |
● Package Size: | 28 | |
● Public Price: | 20.81 EUR | ( 2,015,989.56 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,7432 EUR | ( 0.00 LBP ) |
● Medica Comments: | ACCOLEIT = Accolate | |
● Pricing Date: | 22/09/2017 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 56 | |
● Public Price: | 21.11 EUR | ( 2,045,052.36 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 0,377 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 20 EUR | |
● Pricing Date: | 01/08/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Belgium | |
● Package Size: | 56 | |
● Public Price: | 19.21 EUR | ( 1,860,987.96 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 0,343 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 22/06/2017 | |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File